Notably, EIE-2 exhibits a unique bi-directional regulatory effect on the PKCθ/mTOR ratio, up-regulating it in the model simulating the active phase of RA and down-regulating it in the model simulating the inactive phase. Here, PRRT2 is linked to rheumatoid arthritis.